Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integra Holdings
Jerusalem, Jerusalem District, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
Integra Holdings invests in and develops early- to late-stage companies originating from Hebrew University, with clinical results spanning validation in oncology, cystic fibrosis, and other therapeutic areas; some programs nearing FDA marketing authorization.
- Therapeutic areas
- ImmunologyOphthalmologyInfectious DiseasesPulmonologyOncologyNeurology
- Modalities
- Small moleculeAntisense oligonucleotideLipid-based cytotoxic agentImmune oncology therapyLiposomal drug formulationMedical deviceRNA modulation compounds
- Industry
- Investors
02
Partnerships
OrbimedIBFPeregrineaMoonCF FoundationPontifaxLundbeck fundSROneCBIBiolight LifeSciencesPrivate investors
Beyond the preview
Go deeper on Integra Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Integra Holdings.